Scientific publisher Nature Publishing Group (NPG), UK, and the Australasian Society for Immunology (ASI) have announced a partnership to publish a new open access journal from December 2012. The journal, Clinical and Translational Immunology (CTI), will be a companion title to Immunology and Cell Biology, currently published by NPG in partnership with the ASI. CTI will be hosted on nature.com and will begin accepting submissions in the second half of 2012.
CTI will publish the latest advances in biomedical research for scientists and physicians. The journal will focus on fields such as cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation. CTI will publish articles on basic, translational, and clinical studies in all aspects of human immunology, including experimental models specific to human diseases. There will also be reviews of timely topics in basic immunology, case reports, and letters to the editor.
The editorial team is led by Editor-in-Chief Gabrielle Belz, of the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. An international editorial board supports the editorial team.
All content will be open access and will be freely available to researchers worldwide through the nature.com platform. An article-processing charge (APC) will be levied per article accepted for publication, and authors will have a choice of two Creative Commons licenses.
NPG works with more than 30 societies and organisations worldwide to provide publishing services and publishes over 50 journals in its academic and society journals programme. Open access options are available on more than 90 percent (55 of 59) of NPG's academic and society journal portfolio.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
